165 related articles for article (PubMed ID: 11128033)
1. Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.
Suzuki A; Yasuno T; Kojo H; Hirosumi J; Mutoh S; Notsu Y
Jpn J Pharmacol; 2000 Oct; 84(2):113-23. PubMed ID: 11128033
[TBL] [Abstract][Full Text] [Related]
2. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
[TBL] [Abstract][Full Text] [Related]
3. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
Chen Z; Ishibashi S; Perrey S; Osuga Ji ; Gotoda T; Kitamine T; Tamura Y; Okazaki H; Yahagi N; Iizuka Y; Shionoiri F; Ohashi K; Harada K; Shimano H; Nagai R; Yamada N
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):372-7. PubMed ID: 11231916
[TBL] [Abstract][Full Text] [Related]
7. Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase.
Kobayashi J; Nagashima I; Hikita M; Bujo H; Takahashi K; Otabe M; Morisaki N; Saito Y
Br J Clin Pharmacol; 1999 Apr; 47(4):433-9. PubMed ID: 10233209
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
[TBL] [Abstract][Full Text] [Related]
9. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
[TBL] [Abstract][Full Text] [Related]
11. Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes.
Sugawara A; Takeuchi K; Uruno A; Ikeda Y; Arima S; Sato K; Kudo M; Taniyama Y; Ito S
Hypertens Res; 2001 May; 24(3):229-33. PubMed ID: 11409645
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
13. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
Hofmann CA; Edwards CW; Hillman RM; Colca JR
Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
Kurebayashi S; Hirose T; Miyashita Y; Kasayama S; Kishimoto T
Diabetes; 1997 Dec; 46(12):2115-8. PubMed ID: 9392507
[TBL] [Abstract][Full Text] [Related]
15. Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.
Yang KJ; Noh JR; Kim YH; Gang GT; Hwang JH; Yang SJ; Yeom YI; Lee CH
Life Sci; 2010 Sep; 87(13-14):405-10. PubMed ID: 20723549
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse.
Tang Y; Osawa H; Onuma H; Nishimiya T; Ochi M; Sugita A; Makino H
Diabetes Res Clin Pract; 2001 Dec; 54(3):145-55. PubMed ID: 11689269
[TBL] [Abstract][Full Text] [Related]
17. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
Madhavan GR; Chakrabarti R; Kumar SK; Misra P; Mamidi RN; Balraju V; Kasiram K; Babu RK; Suresh J; Lohray BB; Lohrayb VB; Iqbal J; Rajagopalan R
Eur J Med Chem; 2001; 36(7-8):627-37. PubMed ID: 11600232
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
Aoki K; Kikuchi T; Mukasa K; Ito S; Nakajima A; Satoh S; Okamura A; Sekihara H
Endocr J; 2000 Dec; 47(6):799-804. PubMed ID: 11228057
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes.
Sigrist S; Bedoucha M; Boelsterli UA
Biochem Pharmacol; 2000 Jul; 60(1):67-75. PubMed ID: 10807946
[TBL] [Abstract][Full Text] [Related]
20. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
Loffler M; Bilban M; Reimers M; Waldhäusl W; Stulnig TM
J Pharmacol Exp Ther; 2006 Feb; 316(2):797-804. PubMed ID: 16260581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
